The Eldest of Older Adults Living with HIV: Response and Adherence to Highly Active Antiretroviral Therapy

American Journal of Medicine

Volumn 121, Issue 9, 2008, Pages 820-824

  Brañas, Fátima ^a   Berenguer, Juan ^a   Sánchez Conde, Matilde ^a   López Bernaldo de Quirós, Juan Carlos ^a   Miralles, Pilar ^a   Cosín, Jaime ^a   Serra, José Antonio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Acquired immunodeficiency syndrome; Elderly; Highly active antiretroviral therapy; Human immunodeficiency virus; Older adults

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; ESOPHAGUS CANDIDIASIS; FEMALE; HERPES SIMPLEX; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOBLASTIC LYMPHOMA; KAPOSI SARCOMA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SURVIVAL; THRUSH; TOXOPLASMOSIS; TREATMENT RESPONSE;

AGE FACTORS; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 49849085902     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.05.027     Document Type: Article

References (17)

1. Manfredi R. HIV infection and advanced age emerging epidemiological, clinical, and management issues. Ageing Res Rev 3 (2004) 31-54
2. Statement of Senator Gordon HS. Aging hearing: HIV over fifty, exploring the new threat. Available at http://aging.senate.gov/minority/_files/hr141gs.pdf. Accessed January 11, 2007.
3. Perez J.L., and Moore R.D. Greater effect of highly active antiretroviral therapy on survival in people aged ≥50 years compared with younger people in an urban observational cohort. Clin Infect Dis 36 (2003) 212-218
4. Grabar S., Kousignian I., Sobel A., et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS 18 (2004) 2029-2038
5. Knobel H., Guelar A., Valldecillo G., et al. Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up. AIDS 15 (2001) 1591-1593
6. Centers for Disease Control and Prevention. Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV-infected persons-United States, 1992-1994. MMWR Morb Mortal Wkly Rep 42 (1993) 17-18
7. Department of Health and Human Services. Available at: www.aidsinfo.nih.gov/guidelines/. Accessed October 2006.
8. Chaisson R.E., Keruly J.C., and Moore R.D. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med 333 (1995) 751-756
9. Operskalski E.A., Stram D.O., Lee H., et al. Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group. J Infect Dis 172 (1995) 648-655
10. Castilla J., Sobrino P., De La Fuente L., et al. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 16 (2002) 1945-1951
11. Mugavero M.J., Castellano C., Edelman D., and Hicks C. Late diagnosis of HIV infection: the role of age and sex. Am J Med 120 (2007) 370-373
12. Manfredi R., and Chiodo F. A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS 14 (2000) 1475-1477
13. Manfredi R. HIV disease and advanced age: an increasing therapeutic challenge. Drugs Aging 19 (2002) 647-669
14. Douek D.C., McFarland R.D., Keiser P.H., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 (1998) 690-695
15. Naylor K., Li G., Vallejo A.N., et al. The influence of age on T cell generation and TCR diversity. J Immunol 174 (2005) 7446-7452
16. Grabar S., Weiss L., and Costagliola D. HIV infection in older patients in the HAART era. J Antimicrob Chemother 57 (2006) 4-7
17. Katlama C., Carcelain G., Duvivier C., et al. Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study-ANRS 082. AIDS 16 (2002) 2027-2034